Filana Therapeutics (FLNA)

• Market cap: $63.8M
• 1 day: -5.71%
• 5 days: -14.29%
• 1 month: -4.35%
• 3 months: -35.29%
• 6 months: -58.62%
• Year to date: -36.84%
• 1 year: -37.74%
• 5 years: -98.05%
• 10 years: -91.73%
• Sector: Healthcare
• Industry: Biotechnology

About: Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Employees: 20